A 62-year-old woman with persistent dry eye symptoms has been prescribed acoltremon, a TRPM8 agonist and she asks what to expect. Which counseling point best aligns with clinical trial evidence and real-world considerations? A. You should see improvements in tear production and symptoms within 1 to 2 weeks, though you may experience mild instillation-site discomfortB. You will need to use acoltremon consistently for at least 6 months to experience noticeable symptom relief, so remain adherentC. Systemic adverse events such as fatigue and hypertension are frequently reported and require close monitoring, so report those if you experience themD. You’ll need to consistently use corticosteroid drops alongside acoltremon for the first month to achieve clinical benefit
[Answered]: A 62-year-old woman with persistent dry eye…
Need help with your Cardiovascular Disorders case study or NCLEX preparation? Connect with a verified Nursing expert now.